CLINICAL_TRIALS
trial_result
· 2020-10-28
Clinical Trial Update: Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD [Phase 2]
Summary
Phase 2 trial investigating 4 doses of RPL554 added to tiotropium in COPD completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Verona Pharma plc | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2020-10-28